Schizophrenia, Third Edition

ویرایش:  
 
سری:  
ISBN (شابک) : 9781405176972, 9781444327298 
ناشر: Wiley-Blackwell 
سال نشر: 2011 
تعداد صفحات: 737 
زبان: English 
فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) 
حجم فایل: 15 مگابایت 

قیمت کتاب (تومان) : 44,000

Schizophrenia is one of the most complex and disabling diseases to affect mankind.   Relatively little is known about its nature and its origins, and available treatments are inadequate for most patients. As a result, there are inevitable controversies about what causes it, how to diagnose it, and how best to treat it.   However, in the past decade, there has been an explosion of new research, with dramatic discoveries involving genetic etiology and epidemiological risk factors.  There has also been a catalog of new drugs coming to market, and controversy about the relative advantages and disadvantages of newer compared with older therapies.   In addition, developing technologies in genomics, molecular biology and neuroimaging provide streams of new information.

This book represents a definitive, essential, and up-to-date reference text on schizophrenia. It extensively and critically digests and clarifies recent advances and places them within a clinical context.  The Editors (one American and one British), highly respected clinical psychiatrists and researchers and acknowledged experts on schizophrenia, have again assembled an outstanding group of contributors from the USA, UK, Europe and Australia, It will be of value to practising psychiatrists and to trainees, as well as to clinical and neuroscience researchers interested in keeping up with this field or coming into it.

The book consists of four sections:   descriptive aspects, biological aspects, physical treatments, and psychological and social aspects.   It reviews the theoretical controversies over symptomatology, classification and aetiology (particularly pertinent as DSM-V is being developed), the relationship of schizophrenia to the other psychoses, the significance of positive and negative symptoms and pre-morbid personality. It describes a variety of approaches to integrating the vast research data about schizophrenia, including neurodevelopmental, genetic, pharmacological, brain imaging and psychological findings. The biological treatment section reviews the comparative efficacy of various drugs, the management of drug-resistant patients and both neurological and metabolic complications. The final section looks at psychological therapies, social outcomes, and the economics of schizophrenia. 

Highly Commended in the Psychiatry section of the 2012 BMA Book Awards.

Content:
Chapter 1 Concept of Schizophrenia: Past, Present, and Future (pages 1–8): Nancy C. Andreasen
Chapter 2 The Schizophrenia Construct: Symptomatic Presentation (pages 09–23): Celso Arango and William T. Carpenter
Chapter 3 Child and Adolescent Schizophrenia (pages 24–46): Chris Hollis and Judith Rapoport
Chapter 4 Late?Onset Schizophrenia (pages 47–61): Robert Howard and Dilip Jeste
Chapter 5 The Schizophrenia Spectrum Personality Disorders (pages 62–90): Eran Chemerinski and Larry J. Siever
Chapter 6 The Prodrome of Schizophrenia (pages 91–103): Jean Addington and Shon W. Lewis
Chapter 7 Course and Outcome (pages 104–141): Wolfram an der Heiden and Heinz Hafner
Chapter 8 Neurocognitive Impairments in Schizophrenia: Their Character and Role in Symptom Formation (pages 142–162): Terry E. Goldberg, Anthony David and James. M. Gold
Chapter 9 The Secondary Schizophrenias (pages 163–184): Thomas M. Hyde and Maria A. Ron
Chapter 10 Schizophrenia: The Epidemiological Horizon (pages 185–225): Assen Jablensky, James B. Kirkbride and Peter B. Jones
Chapter 11 Environmental Risk Factors for Schizophrenia (pages 226–244): John J. McGrath and Robin M. Murray
Chapter 12 Classical Genetic Studies of Schizophrenia (pages 245–268): Brien Riley and Kenneth S. Kendler
Chapter 13 Genetic Associations in Schizophrenia (pages 269–288): Michael C. O'Donovan and Michael J. Owen
Chapter 14 Intermediate Phenotypes in Genetic Studies of Schizophrenia (pages 289–310): Michael F. Egan and Tyrone D. Cannon
Chapter 15 Electrophysiology of Schizophrenia (pages 311–333): Georg Winterer and Robert W. McCarley
Chapter 16 Structural Brain Imaging in Schizophrenia and Related Populations (pages 334–352): Stephen M. Lawrie and Christos Pantelis
Chapter 17 Functional Brain Imaging in Schizophrenia (pages 353–371): Andreas Meyer?Lindenberg and Edward T. Bullmore
Chapter 18 Neuropathology of Schizophrenia (pages 372–392): Paul J. Harrison, David A. Lewis and Joel E. Kleinman
Chapter 19 Neurodevelopmental Origins of Schizophrenia (pages 393–412): Daniel R. Weinberger and Pat Levitt
Chapter 20 Dopamine and Schizophrenia (pages 413–432): Anissa Abi?Dargham and Anthony A. Grace
Chapter 21 Contributions of Glutamate and GABA Systems to the Neurobiology and Treatment of Schizophrenia (pages 433–461): John H. Krystal and Bita Moghaddam
Chapter 22 Animal Models of Schizophrenia (pages 462–481): Barbara K. Lipska and Joseph A. Gogos
Chapter 23 Pharmacology and Neuroscience of Antipsychotic Drugs (pages 483–514): John L. Waddington, Colm M. P. O'Tuathaigh and Gary J. Remington
Chapter 24 Principles of Pharmacological Treatment in Schizophrenia (pages 515–524): Thomas R. E. Barnes and Stephen R. Marder
Chapter 25 Comparative Efficacy and Effectiveness in the Drug Treatment of Schizophrenia (pages 525–539): John R. Geddes, T. Scott Stroup and Jeffrey A. Lieberman
Chapter 26 Approaches to Treatment?Resistant Patients (pages 540–560): Stephan Leucht, Christoph U. Correll and John M. Kane
Chapter 27 Neurological Complications of Antipsychotic Drugs (pages 561–576): Peter M. Haddad and Venkata S. Mattay
Chapter 28 Metabolic Adverse Effects Associated with Antipsychotic Medications (pages 577–597): John W. Newcomer and Stefan Leucht
Chapter 29 Schizophrenia and Psychosocial Stresses (pages 599–624): Paul E. Bebbington and Elizabeth Kuipers
Chapter 30 Mental Health Services for Patients with Schizophrenia (pages 625–643): Tom Burns and Bob Drake
Chapter 31 Societal Outcomes in Schizophrenia (pages 644–665): Iain Kooyman and Elizabeth Walsh
Chapter 32 Psychological Treatment of Psychosis (pages 666–686): Gillian Haddock and Will Spaulding
Chapter 33 Economics of the Treatment of Schizophrenia (pages 687–699): Nancy H. Covell, Susan M. Essock and Linda K. Frisman

fmatter......Page 2
ins......Page 16
ch1......Page 24
ch2......Page 31
ch3......Page 46
ch4......Page 69
ch5......Page 84
ch6......Page 113
ch7......Page 126
ch8......Page 164
ch9......Page 185
ch10......Page 206
ch11......Page 247
ch12......Page 266
ch13......Page 290
ch14......Page 310
ch15......Page 332
ch16......Page 355
ch17......Page 374
ch18......Page 393
ch19......Page 414
ch20......Page 434
ch21......Page 454
ch22......Page 483
ch23......Page 503
ch24......Page 534
ch25......Page 544
ch26......Page 559
ch27......Page 580
ch28......Page 596
ch29......Page 617
ch30......Page 642
ch31......Page 661
ch32......Page 683
ch33......Page 704
index......Page 717